Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00052
Species: Homo sapiens
Position : chr7:131323622-131334609
Year: 2024
Title: CRISPR Screening of Transcribed Super-Enhancers Identifies Drivers of Triple-Negative Breast Cancer Progression
Genome Build: hg19
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: Triple-negative breast cancer
PMID:  39186674
MONDO: MONDO:0005228
Tissue: Mammary gland
Tissue Ontology ID: UBERON:0001911
Cell Source: MDA-MB-231
CVCL ID: CVCL_0062
Cell Type: Triple-negative breast cancer cell line
Cell Ontology ID: CL:0009071
Experiment Type: CRISPR-Cas9 knockout loss-of-function, dCas9-KRAB CRISPRi repression, Hi-C chromatin looping validation, CasRx eRNA knockdown
High Throughput Method: ChIP-seq(H3K27ac), GRO-seq, ATAC-seq, RNA-seq, Hi-C, scATAC-seq, scRNA-seq, TCGA bulk omics
Low Throughput Method: qRT-PCR, transwell migration assay, crystal violet proliferation assay, mouse mammary fat pad xenograft, tail vein metastasis model, IHC staining
About Target Gene
Target gene : PODXL
About TF
TF name :
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 2 found
Enhancer ID Position Tissue Cell Disease
E_00051 chr7:131323622-131334609 Mammary gland Triple-negative breast cancer cell line Triple-negative breast cancer
E_00053 chr7:131323622-131334609 Mammary gland Triple-negative breast cancer cell line Triple-negative breast cancer
Expression of Target Genes for the Enhancer